F. Lavorini (Firenze (FI), Italy), T. Bahmer (Kiel, Germany)
Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study
D. Ramos Apolaya (Sevilla, Spain), M. Romero Falcón (Sevilla, Spain), J. Medina Gallardo (Sevilla, Spain), A. Gómez-Bastero Fernández (Sevilla, Spain), F. Alvarez Gutierrez (sevilla, Spain), J. Delgado Romero (sevilla, Spain), C. Campos Sien (sevilla, Spain), P. Rytilä (Spoo, Finland)
|   |
Inhaler technique training of community pharmacists and common errors
B. Milenkovic (Belgrade, Republic of Serbia), M. Roganovic (Belgrade, Republic of Serbia), M. Kovacevic (Belgrade, Republic of Serbia), M. Culafic (Belgrade, Republic of Serbia), . Jovanovic (Belgrade, Republic of Serbia), K. Vucicevic (Belgrade, Republic of Serbia), S. Vezmar Kovacevic (Belgrade, Republic of Serbia), B. Miljkovic (Belgrade, Republic of Serbia)
| |
Peak inspiratory flow measured at different inhaler resistances in patients with asthma
J. Haughney (Glasgow, United Kingdom), I. Pertsovskaya (Swaffham, United Kingdom), A. Lee (Aberdeen, United Kingdom), E. McKnight (Swaffham, United Kingdom), M. O'Driscoll (Swaffham, United Kingdom), O. Usmani (London, United Kingdom)
| |
Bacterial colonization of home nebulizers used by children suffering from recurrent wheeze.
N. Navkiran (Chandigarh, India), S. Randev (Chandigarh, India), N. Singla (Chandigarh, India)
| |
Comparing five antistatic valved holding chambers: how antistatic are they really?
P. Hagedoorn (Groningen, Netherlands), F. Grasmeijer (Groningen, Netherlands), W. Bawari (Groningen, Netherlands), H. Frijlink (Groningen, Netherlands), F. Grasmeijer (Groningen, Netherlands)
| |
Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer
B. Demouveaux (Valognes, France), A. Vanlaeys (Valognes, France), T. Porée (Valognes, France)
| |
Long-term clinical effect of inhalation method with lowered tongue.
. Kondo (Nagoya, Japan), T. Horiguchi (Nagoya, Japan), Y. Tohda (Osaka, Japan)
| |
How to assess inhalation technique in patients with asthma and COPD – comparison ofthree different methods
M. Miszczuk (Warszawa, Poland), I. Domagala (Warszawa, Poland), M. Dabrowska (Warszawa, Poland), M. Maskey-Warzechowska (Warszawa, Poland), R. Krenke (Warszawa, Poland)
| |
Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use
J. Suggett (London (ON), Canada), A. Ellery (London (ON), Canada)
| |
Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma
M. Kupczyk (Lodz, Poland), P. Majak (Lodz, Poland), P. Kuna (Lodz, Poland), B. Asankowicz-Bargiel (Ostrow Wlkp., Poland), E. Baranska (Chodziez, Poland), R. Dobek (Wolow, Poland), S. Garbicz (Slupsk, Poland), J. Jerzynska (Lodz, Poland), A. Latos (Kielce, Poland), W. Machowiak (Koscian, Poland), B. Majorek-Olechowska (Tarnow, Poland), A. Olech-Cudzik (Ostrowiec Sw., Poland), I. Poziomkowska-Gesicka (Szczecin, Poland), M. Rulewicz-Warniello (Ketrzyn, Poland), A. Swiderska (Wielun, Poland), M. Tarnowski (Warsaw, Poland), P. Kopyto (Lodz, Poland)
| |
Life Cycle Assessment (LCA) and Cradle-to-Grave (CTG) Carbon Footprint of a Multidose Reservoir Dry Powder Inhaler
K. Borenius (Espoo, Finland), V. Vartiainen (Espoo, Finland), A. Takala (Espoo, Finland), J. Haikarainen (Espoo, Finland), G. Parker (Hampshire, United Kingdom), N. Paronen (Espoo, Finland), T. Haahtela (Helsinki, Finland)
| |
Assessment of inhalation technique and satisfaction with inhalers in asthmatic patients
H. Blibech (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), H. Snene (Tunis, Tunisia), A. Zaafouri (Tunis, Tunisia), L. Kaabi (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
In vitro fine particle dose of drug formulation used in asthma & COPD
L. Slator (Chichester (West Sussex), United Kingdom), D. Von Hollen (Murraysville, United States of America), L. Hardaker (Chichester (West Sussex), United Kingdom)
| |
The influence of inhalation flow and aerosol size on deposition: modelled vs. clinical data
L. Tolboom (Enschede, Netherlands), W. De Kruijf (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands)
| |
Orally inhaled drug particle deposition efficiency in subjects with two-level laryngotracheal stenosis
D. Frank-Ito (Durham, NC, United States of America)
| |
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
N. Trushenko (Moscow, Russian Federation), A. Stoliarevichh (Moscow, Russian Federation), B. Andryukov (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation)
| |
Development of image processing-based smartphone App (Application Software) for self-management of inhaled medicines for patients with asthma or COPD
Y. Setoguchi (Tokyo, Japan), Y. Miyazaki (Tokyo, Japan), Y. Nakayama (Tokyo, Japan), L. Matsuyama (Tokyo, Japan), M. Ando (Tokyo, Japan), S. Matsuba (Tokyo, Japan), M. Uchida (Tokyo, Japan)
| |
Devise use errors among patients with asthma and COPD-A real-life study
A. Papaioannou (Chaidari (Athens), Greece), K. Bartziokas (Chaidari (Athens), Greece), G. Hillas (Athens, Greece), E. Fouka (Thessaloniki, Greece), A. Dimakou (Athens, Greece), M. Kallieri (Chaidari (Athens), Greece), S. Tsikrika (Athens, Greece), G. Papadaki (Chaidari (Athens), Greece), E. Papathanasiou (Chaidari (Athens), Greece), A. Papaporfyriou (Chaidari (Athens), Greece), V. Apollonatou (Chaidari (Athens), Greece), G. Verykokou (Chaidari (Athens), Greece), M. Mplizou (Chaidari (Athens), Greece), D. Papakosta (Thessaloniki, Greece), E. Manali (Chaidari (Athens), Greece), S. Papiris (Chaidari (Athens), Greece), S. Loukides (Chaidari (Athens), Greece)
| |